Readystate Asset Management LP Makes New $1.40 Million Investment in Sabra Healthcare REIT, Inc. $SBRA

Posted by Stanley Muller on Sep 8th, 2026

Readystate Asset Management LP bought a new stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 71,748 shares of the real estate investment trust’s stock, valued at approximately $1,400,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of SBRA. Principal Financial Group Inc. boosted its stake in shares of Sabra Healthcare REIT by 0.4% during the 1st quarter. Principal Financial Group Inc. now owns 25,052,121 shares of the real estate investment trust’s stock valued at $481,755,000 after buying an additional 98,770 shares during the last quarter. Nuveen LLC grew its position in Sabra Healthcare REIT by 28.6% in the 4th quarter. Nuveen LLC now owns 7,303,254 shares of the real estate investment trust’s stock valued at $138,324,000 after buying an additional 1,625,072 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Sabra Healthcare REIT by 2.9% in the fourth quarter. Geode Capital Management LLC now owns 7,018,556 shares of the real estate investment trust’s stock valued at $132,949,000 after acquiring an additional 198,118 shares in the last quarter. Bank of America Corp DE increased its position in shares of Sabra Healthcare REIT by 9.4% during the 3rd quarter. Bank of America Corp DE now owns 5,224,116 shares of the real estate investment trust’s stock valued at $97,378,000 after purchasing an additional 447,528 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its holdings in Sabra Healthcare REIT by 7.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,723,546 shares of the real estate investment trust’s stock worth $89,464,000 after acquiring an additional 334,737 shares during the period. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on SBRA shares. Wall Street Zen upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Sunday, June 28th. UBS Group set a $25.00 target price on Sabra Healthcare REIT in a report on Wednesday, July 22nd. Truist Financial increased their price objective on Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a “buy” rating in a report on Wednesday, July 22nd. Scotiabank cut their price objective on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating on the stock in a research report on Thursday, June 18th. Finally, Citizens Jmp raised their target price on Sabra Healthcare REIT from $23.00 to $25.00 and gave the company a “market outperform” rating in a report on Wednesday, July 22nd. Six research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $22.17.

Read Our Latest Stock Analysis on SBRA

Sabra Healthcare REIT Price Performance

Shares of SBRA stock opened at $20.78 on Tuesday. The company has a market capitalization of $5.31 billion, a P/E ratio of 79.93, a P/E/G ratio of 1.58 and a beta of 0.65. Sabra Healthcare REIT, Inc. has a 12 month low of $17.17 and a 12 month high of $22.77. The stock has a 50 day moving average of $20.63 and a two-hundred day moving average of $20.19. The company has a current ratio of 3.07, a quick ratio of 3.07 and a debt-to-equity ratio of 0.95.

Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last announced its quarterly earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by ($0.27). Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The business had revenue of $230.11 million during the quarter, compared to the consensus estimate of $219.39 million. During the same period last year, the firm earned $0.38 EPS. The company’s quarterly revenue was up 24.7% compared to the same quarter last year. As a group, equities analysts expect that Sabra Healthcare REIT, Inc. will post 1.52 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Friday, August 14th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, August 14th. This represents a $1.20 annualized dividend and a yield of 5.8%. Sabra Healthcare REIT’s payout ratio is currently 461.54%.

Sabra Healthcare REIT Profile

(Free Report)

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.